Generics Bulletin is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sandoz’ Unique Chinese Approval Paves The Way For Tender Access

Executive Summary

Sandoz says a first-of-its-kind Chinese approval for generic rosuvastatin will open the door for the firm to participate in local tenders.

Advertisement

Related Content

China Beckons: Sun Joins Indian Firms Priming For Larger Presence
Novartis Selects GSK’s Saynor As Next Sandoz CEO
Sandoz Forms Insulin Biosimilars Deal With Gan & Lee
Sandoz Sees Market Opening Up In China

Topics

Related Companies

What to read next

Advertisement
UsernamePublicRestriction

Register

GB140312

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel